48 Top Stock Pitches (26th-1st November) [NO PAYWALL] 🖨️
Capital Employed rounds up 48 stock pitches, led by Greystone’s $14.50 target for organ-transplant logistics firm Strata Critical Medical, versus $4.70.
Capital Employed rounds up 48 stock pitches, led by Greystone’s $14.50 target for organ-transplant logistics firm Strata Critical Medical, versus $4.70.
E.W. Scripps $SSP raising political guide 40% over the 2022 midterms. Broadcasters are sleeping giants. https://t.co/vLVp6x77mY
the letter attached to the 13-D $WEN https://t.co/3xk6BaceiM https://t.co/MvityYj8DK
"Trian, a longtime shareholder in Wendy’s, is leading a group that has offered to pay $7.35 a share" $WEN Nelson Peltz’s Trian Offers to Buy Wendy’s for $1.4 Billion https://t.co/3FaWClezcx
@richtrades100 $MGM bid for $PPLI likely on hold for now… https://t.co/fH5yRtN3wx
Activist idea: $MAT trades at $15 and is down 30% over 5yrs (earnings hammered with tariffs, supply chain, etc.) 3 top holders pushing for a sale CEO just left to join SKYD Authentic Brands and Zuru both rumored to be interested (L Catterton approached them 2 years ago too) Hmm...
Google issued equity before SPCX was public. And they’d have had to wait until after a lockup expiry, as will AMZN if they want to sell $ANT. Google also paying some spot compute at $50B/GW so timing of cap raise matters more. And I think just a bit more balance sheet conservative culture, and stock was up 100% in a year and at valuation range highs. I have no issue w/ decision $GOOG made in context.
Greenlight on two additional sources of $CENX value: 1) Oklahoma smelter tariff incentive: CENX equity investment ~$760m, and will yield ~$225m annual subsidy 2) Recent EU smelter sale suggests Iceland could be sold for 65% of EV, making Century Aluminum 100% American https://t.co/aF2ZMCNMBd
Travelzoo’s roughly 400,000 prepaid members generate deferred revenue while acquisition costs hit GAAP earnings immediately, masking the…
Altria raised 2026 adjusted EPS guidance to $5.66 to $5.74 and authorized more buybacks, while on! loses share as cigarette margins hold.
Sleep Well Portfolio adds two AI infrastructure suppliers and trims CrowdStrike at a 140x free-cash-flow valuation and $270 billion market…
Portfolio returned over 15% in October, lifting cumulative gains to 103.5%, while adding 3i Group and increasing Floor & Decor and…
Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet…
Amazon reported Q3 2026 net sales up 12% year over year to $201.9 billion, narrowly below the $202.3 billion consensus estimate.
AAOI, Lumentum and Coherent 800G ramps, NVIDIA Rubin timing, and AMD, Intel and Arm server CPU demand frame an expert call on AI…
Verra Mobility’s Avis termination threatens 2027 earnings, while Government Solutions profit rose 25% and implied fourth-quarter guidance…
FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…
Microsoft’s Azure grew 48% as AI monetization accelerated, but doubled CapEx, largely for CPUs and GPUs, reduced quarterly free cash flow…
T · short AT&T’s stalled deleveraging and share repurchase case has prompted a bearish turn on the telecom stock.
Alphabet trades below 20x forward earnings after a 30% drop from 2026 highs, while 31.8% operating margins and AI capex frame the…
Life360 has fallen 60% despite 40% revenue growth, 100 million monthly users and profitability, as its family-safety subscriptions and…
Anthropic’s revenue growth slowed from 147% in Q2 to 45% in Q3, raising questions about AI capital spending as Amazon holds capex flat.
American Tower could gain $1.13 to $3.54 in AFFO per share if Starlink accesses 80,000 U.S. cell sites and becomes a fourth major tenant.
Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…
AstraZeneca reported $16.2 billion Q3 revenue, up 7%, as oncology grew 17% and Farxiga fell 25% after US generics.
Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.
SK hynix's U.S. ADR trades at a valuation discount despite AI-driven memory demand, with 50% of 2027–2028 capacity under long-term…
Bloom may have reopened imports of scandium-containing components from China to the United States, according to new trade data.
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.